Paclitax 300 Injection 50ml

Paclitax 300 Injection 50ml is used for the following:

• Treatment of advanced ovarian cancer

• First-line therapy for breast cancer

• Alternative treatment when other cancer medicines fail

• Management of non-small cell lung cancer

• Therapy for inoperable lung tumours

• Treatment of AIDS-related Kaposi's sarcoma

• Cancer care when surgery isn't suitable

• Therapy after anthracycline treatment proves ineffective

• Treatment when platinum-containing medicines are insufficient

• Management of early and advanced breast cancer stages

Follow these instructions when Paclitax 300 Injection 50ml is administered:

• This medicine is given only in hospital settings under medical supervision.

• The injection is administered through an intravenous (into a vein) infusion.

• Special pre-medication is often given 30-60 minutes before the injection to prevent allergic reactions.

• The medicine is diluted before administration.

• Consult your doctor about any concerns during treatment.

Paclitax 300 Injection 50ml is administered intravenously.

Paclitax 300 Injection 50ml contains paclitaxel (300 mg), which works on the body as follows:

• Microtubule disruption: Paclitaxel interferes with structures called microtubules inside cancer cells, which are essential components needed for cell division and multiplication.

• Cell division prevention: By binding to microtubules, paclitaxel prevents cancer cells from completing their normal division processes, stopping them from multiplying.

• Cell cycle arrest: The medicine causes cancer cells to become stuck during a phase of cell division called mitosis, preventing them from completing the division process.

• Programmed cell death: By disrupting normal cellular functions, paclitaxel ultimately triggers apoptosis (programmed cell death) in cancer cells, causing them to self-destruct.

• Selective targeting: This medicine primarily affects rapidly dividing cells, making it particularly effective against cancer cells while having some selectivity over normal cells.

• Store Paclitax 300 Injection 50ml in its original packaging.

• Keep the vial protected from light and moisture.

• Store in a secure location out of children's reach.

• Do not use the medicine after the expiry date printed on the package.

• Follow storage instructions provided by your hospital pharmacy.

• Maintain good hand hygiene and avoid close contact with people who have infections, as paclitaxel (the active ingredient) can lower your white blood cells, making you more vulnerable to infections.

• Consider consuming small, frequent meals throughout the day rather than three large meals to help manage nausea that may occur during your cancer treatment.